Next-Generation Cancer Vaccines: Personalized, mRNA, and AI-Driven Innovations
Next-generation cancer vaccines are revolutionizing oncology by combining personalized design, mRNA technology, and artificial intelligence (AI). Unlike traditional vaccines that target a single common antigen, these vaccines are tailored to each patient’s tumor, addressing the challenge of tumor heterogeneity and improving treatment specificity. The process begins with tumor sequencing to identify unique mutations called neoantigens. […]
Next-Generation Cancer Vaccines: Personalized, mRNA, and AI-Driven Innovations Read More »